SLNSW-CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, ...-TN_cdi_proquest_journals_2593649696

CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study

Full title: CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study

Author/creator: Naing, Aung, Thistlethwaite, Fiona, De Vries, Elisabeth G.E., Eskens, Ferry A.L.M., Uboha, Nataliya, Ott, Patrick A., LoRusso, Patricia, Garcia-Corbacho, Javier, Boni, Valentina, Bendell, Johanna, Autio, Karen A., Randhawa, Manreet, Durm, Greg, Gil-Martin, Marta, Stroh, Mark, Hannah, Alison L., Arkenau, Hendrik-Tobias, Spira, Alexander.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_2593649696

Language: English

Formats: Articles

Publishers: England: BMJ Publishing Group LTD

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2593649696

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study

    Record identifier

    TN_cdi_proquest_journals_2593649696

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2593649696

    Share

    CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2593649696

    CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study

    Full title

    CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study

    Author / Creator

    Naing, Aung ; Thistlethwaite, Fiona ; De Vries, Elisabeth G.E. ; Eskens, Ferry A.L.M. ; Uboha, Nataliya ; Ott, Patrick A. ; LoRusso, Patricia ; Garcia-Corbacho, Javier ; Boni, Valentina ; Bendell, Johanna ; Autio, Karen A. ; Randhawa, Manreet ; Durm, Greg ; Gil-Martin, Marta ; Stroh, Mark ; Hannah, Alison L. ; Arkenau, Hendrik-Tobias ; Spira, Alexander

    Publisher

    England: BMJ Publishing Group LTD

    Journal title

    Journal for immunotherapy of cancer, 2021, Vol.9 (7), p.e002447

    Record Identifier

    TN_cdi_proquest_journals_2593649696

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    1506 2435 Adult Aged Aged, 80 and over ANTIBODY Antigens ATEZOLIZUMAB B7-H1 antigen Biomarkers Biopsy Cancer therapies CARCINOMA Chemotherapy Clinical Drug dosages Female Humans Immune Checkpoint Inhibitors - pharmacology Immune Checkpoint Inhibitors - therapeutic use Immunotherapy Immunotherapy - methods investigational Male Metastasis Middle Aged Monoclonal antibodies Neoplasms - drug therapy Patients PEMBROLIZUMAB Peptides Radiation therapy SAFETY Steroids therapies Translational Cancer Immunotherapy Tumors Young Adult

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_2593649696

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2593649696

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections